Functional polymorphisms in Egr3 and its regulatory targets such as Arc may prove useful biomarkers for sensitivity to the negative impacts of sleepiness on cognition, as they have for symptoms of schizophrenia risk (Huentelman et al., 2015). This evidence concerns the gene ARC and schizophrenia.